Musculoskeletal & Pain Research
Osteoarthritis
Osteoarthritis (OA) is one of the most common degenerative joint diseases, affecting millions of adults worldwide. CenExel partners with sponsors to advance innovative osteoarthritis therapies through specialized clinical research, experienced investigators, and access to diverse patient populations across multiple research sites.
Advancing Osteoarthritis Clinical Research
CenExel provides specialized scientific and operational expertise for osteoarthritis clinical trials. Our experienced teams support studies focused on pain reduction, mobility improvement, inflammation management, and long-term joint health outcomes. From early-phase research to large multicenter trials, we help accelerate therapeutic innovation for patients living with osteoarthritis.
Improve Patient Mobility
Accelerate Study Enrollment
Osteoarthritis Conditions We Research
Our osteoarthritis research programs support a broad range of musculoskeletal and degenerative joint conditions across multiple therapeutic areas.
- Knee Osteoarthritis
- Hip Osteoarthritis
- Hand Osteoarthritis
- Spine Osteoarthritis
- Degenerative Joint Disease
- Chronic Joint Pain
- Post-Traumatic Osteoarthritis
- Cartilage Degeneration
Why Sponsors Choose CenExel for Osteoarthritis
CenExel combines scientific expertise, advanced recruitment strategies, and operational excellence to support successful osteoarthritis clinical trials across all study phases.
01
Specialized Pain Research Teams
Experienced investigators and site staff focused on musculoskeletal and pain-related clinical research.
02
Diverse Patient Recruitment
Nationwide access to diverse patient populations with osteoarthritis and related joint conditions.
03
Advanced Biomarker & Imaging Support
Support for imaging endpoints, mobility assessments, and biomarker-driven osteoarthritis studies.
04
Efficient Trial Execution
Streamlined operations and centralized coordination to accelerate enrollment and improve study timelines.
Supported Osteoarthritis Trial Phases
CenExel supports osteoarthritis clinical research from early proof-of-concept studies through large-scale Phase IV trials.
Active across all phases
- Phase I
- Phase II
- Phase III
- Phase IV
Our experienced research teams provide operational support for musculoskeletal and osteoarthritis studies including patient recruitment, imaging coordination, pain assessments, and long-term follow-up programs.
Osteoarthritis Task Force
CenExel supports osteoarthritis and musculoskeletal research across a nationwide network of clinical sites, focusing on pain management, mobility improvement, inflammation reduction, and long-term joint health outcomes.






